Main Menu
Main Menu
On Glioblastoma Awareness Day, we shine a light on glioblastoma (GBM), the most common, complex, treatment-resistant, and deadliest type of brain cancer.
National Brain Tumor Society spearheaded this annual event in 2019 to support survivors and their loved ones, to remember those who are no longer with us, and to honor luminaries working toward a cure and better quality of life for those who are living with this devastating disease.
who will receive a glioblastoma diagnosis in 2022
is the five-year survival rate for glioblastoma patients
will succumb to glioblastoma this year
have been approved by the FDA — and one device — for glioblastoma